Argonaut Manufacturing Services, a contract manufacturing organization (CMO), and n-Lorem, a nonprofit foundation, have formed a new partnership that supports and reduces the cost of manufacturing of n-Lorem’s experimental antisense oligonucleotide (ASO) medicines developed for nano-rare disease patients (1 to 30 patients worldwide) for free, for life.  “Providing nano-rare patients, who would otherwise be largely ignored by our current drug discovery paradigm, with a personalized approach fo...